within Pharmacolibrary.Drugs.V_Various.V09C_RenalSystem.V09CX03_SodiumIothalamate125i;

model SodiumIothalamate125i
  extends Pharmacolibrary.Drugs.ATC.V.V09CX03;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>V09CX03</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Sodium iothalamate (125I) is a radiolabeled contrast agent primarily used for the measurement of glomerular filtration rate (GFR) in clinical investigations. It is not used for therapeutic purposes but serves as a diagnostic agent. It is currently approved and used for renal function assessment.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult subjects following intravenous bolus injection for renal plasma clearance testing.</p><h4>References</h4><ol><li><p>Welling, PG, et al., &amp; Madsen, PO (1976). Pharmacokinetics of 125I-iothalamate and 131I-o-iodohippurate in man. <i>Journal of clinical pharmacology</i> 16(2-3) 142–148. DOI:<a href=\"https://doi.org/10.1002/j.1552-4604.1976.tb02395.x\">10.1002/j.1552-4604.1976.tb02395.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1254735/\">https://pubmed.ncbi.nlm.nih.gov/1254735</a></p></li><li><p>Perrone, RD, et al., &amp; Hunsicker, LG (1990). Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. <i>American journal of kidney diseases : the official journal of the National Kidney Foundation</i> 16(3) 224–235. DOI:<a href=\"https://doi.org/10.1016/s0272-6386(12)81022-5\">10.1016/s0272-6386(12)81022-5</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2205098/\">https://pubmed.ncbi.nlm.nih.gov/2205098</a></p></li><li><p>Roth, S, et al., &amp; Lange, H (1976). Pharmacokinetics of sisomicin in patients with normal and impaired renal function; its efficacy in urinary tract infection. <i>European journal of clinical pharmacology</i> 10(5) 357–365. DOI:<a href=\"https://doi.org/10.1007/BF00565626\">10.1007/BF00565626</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/789084/\">https://pubmed.ncbi.nlm.nih.gov/789084</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end SodiumIothalamate125i;
